$Histogenics(OCGN)$COVAXIN has received Emergency Use Authorizations in several countries across the globe with another 60 in process. EUA’s have now been obtained from Mexico, Philippines, Iran, Paraguay, Guatemala, Nicaragua, Guyana, Venezuela, Botswana, Zimbabwe, among several other countries. EUA’s are in process in the USA and several European countries. Pricing for international markets and supplies to govt’s under EUA’s have been established between $15 - 20 / dose.https://www.bharatbiotech.com/images/press/bharat-biotech-covaxin-capacity-expansion-to-worldwide.pdf
$Grab Holdings(GRAB)$ like how most comments telling ppl not to buy are from the same bunch yet they kept coming back to comment [捂脸] its like smelling shit and tell others it is smelly but yet ownself continue to keep smelling it
$Histogenics(OCGN)$”John Paul (J.P.) Gabriel is a seasoned biopharmaceutical manufacturing professional with over 25 years of industry experience. Over the course of his career, Mr. Gabriel has held leadership positions with Sanofi Pasteur (formerly Connaught Laboratories), Pfizer Vaccines (formerly Wyeth), Genentech/Roche, and most recently with Ultragenyx Pharmaceutical, where he was Vice President of Biologics and mRNA Manufacturing.”